Ahmed Mohsen: How Should D-Dimer Be Interpreted in Pregnancy?
Ahmed Mohsen, Associated Professor of Cardiology at Cairo University, shared a post on LinkedIn:
“Cardiology Challenge!
A pregnant lady presents with unexplained dyspnea… You suspect Pulmonary Embolism (PE)
What is the most important test to request first?
Check the ideal answer from my book: Tips and Tricks in Cardiology
Follow the Pregnancy-Adapted YEARS Algorithm
Many physicians immediately think of CTPA
Not always!
If YEARS criteria are present, the first step is:
Lower Limb Venous Duplex Ultrasound
Why?
- If DVT is confirmed, anticoagulation should be started immediately
- No need to expose the mother or fetus to additional radiation
- No need to prove PE with further imaging in most cases
Also remember:
D-dimer can still be useful during pregnancy —but it should be interpreted using the Pregnancy-Adapted YEARS algorithm, not the conventional cut-off.
Key Tip:
A positive lower limb venous duplex in a pregnant patient with suspected PE may save the patient from unnecessary CTPA and radiation exposure.
Tip from my book:
Tips and Tricks in Cardiology
Practical. Guideline-based. Board-exam friendly.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin